Pratt BE[au] - Search Results

Year	Number of Results
1995	1
1997	1
2000	1
2007	1
2013	1
2014	1
2015	1
2017	1
2018	1
2024	0

1

Iodine-131 monitoring in sewage plant outflow.

McGowan DR, Pratt BE, Hinton PJ, Peet DJ, Crawley MT. McGowan DR, et al. Among authors: pratt be. J Radiol Prot. 2014 Mar;34(1):1-14. doi: 10.1088/0952-4746/34/1/1. Epub 2013 Nov 22. J Radiol Prot. 2014. PMID: 24270089

2

InfuShield: a shielded enclosure for administering therapeutic radioisotope treatments using standard syringe pumps.

Rushforth DP, Pratt BE, Chittenden SJ, Murray IS, Causer L, Grey MJ, Gear JI, Du Y, Flux GD. Rushforth DP, et al. Among authors: pratt be. Nucl Med Commun. 2017 Mar;38(3):266-272. doi: 10.1097/MNM.0000000000000634. Nucl Med Commun. 2017. PMID: 28187040 Free PMC article.

3

Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from castration resistant prostate cancer.

Pratt BE, Hindorf C, Chittenden SJ, Parker CC, Flux GD. Pratt BE, et al. Nucl Med Commun. 2018 Feb;39(2):125-130. doi: 10.1097/MNM.0000000000000783. Nucl Med Commun. 2018. PMID: 29189490

4

Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography.

Crawford DC, Flower MA, Pratt BE, Hill C, Zweit J, McCready VR, Harmer CL. Crawford DC, et al. Among authors: pratt be. Eur J Nucl Med. 1997 Dec;24(12):1470-8. doi: 10.1007/s002590050176. Eur J Nucl Med. 1997. PMID: 9391181

5

A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases.

Chittenden SJ, Hindorf C, Parker CC, Lewington VJ, Pratt BE, Johnson B, Flux GD. Chittenden SJ, et al. Among authors: pratt be. J Nucl Med. 2015 Sep;56(9):1304-9. doi: 10.2967/jnumed.115.157123. Epub 2015 Jul 16. J Nucl Med. 2015. PMID: 26182965 Free article. Clinical Trial.

6

Optimization of equipment and methodology for whole body activity retention measurements in children undergoing targeted radionuclide therapy.

Chittenden SJ, Pratt BE, Pomeroy K, Black P, Long C, Smith N, Buckley SE, Saran FH, Flux GD. Chittenden SJ, et al. Among authors: pratt be. Cancer Biother Radiopharm. 2007 Apr;22(2):243-9. doi: 10.1089/cbr.2006.315. Cancer Biother Radiopharm. 2007. PMID: 17600471

7

False positive 131I whole body scans in thyroid cancer.

Mitchell G, Pratt BE, Vini L, McCready VR, Harmer CL. Mitchell G, et al. Among authors: pratt be. Br J Radiol. 2000 Jun;73(870):627-35. doi: 10.1259/bjr.73.870.10911786. Br J Radiol. 2000. PMID: 10911786

8

Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management.

Wilson CB, Young HE, Ott RJ, Flower MA, Cronin BF, Pratt BE, McCready VR, Horwich A. Wilson CB, et al. Among authors: pratt be. Eur J Nucl Med. 1995 Jun;22(6):508-13. doi: 10.1007/BF00817273. Eur J Nucl Med. 1995. PMID: 7556294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year